Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ONESOURCE Stock Analysis
Views
Red Flags
Positive
High and improving operating margin
Strong revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low and declining Debt to Equity
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Low dividend yield
Neutral
Low ROE but improving trend
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
ONESOURCE Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ONESOURCE Bulk, Block & Insider Trades
ONESOURCE Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). T... Read More
Key personnel
Mr. Anurag Bhagania
Chief Financial Officer
Ms. Allada Trisha
Company Secretary, Compliance Officer
Mr. Neeraj SharmaD
Managing Director, Executive Director
Mr. Bhushan Sudhir BopardikarD
Non-Executive Director
Mr. Arun Kumar PillaiD
Non-Executive Director, Founder
Dr. Rashmi Harshadrai BarbhaiyaD
Independent Director
Dr. Claudio AlbrechtD
Non-Executive Independent Director
Mr. Colin Michael BondD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Onesource Specialty Pharma Ltd.?
The current share price of Onesource Specialty Pharma Ltd. is ₹ 1,759.03 as of 09 Jan 2026.
What is the PE ratio of Onesource Specialty Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Onesource Specialty Pharma Ltd. is 504.50 as of the latest financial data.
What is the ROE and ROCE of Onesource Specialty Pharma Ltd.?
Onesource Specialty Pharma Ltd. has a Return on Equity (ROE) of 1.27% and a Return on Capital Employed (ROCE) of 5.96% as per the latest financial reports.
What is the market cap of Onesource Specialty Pharma Ltd.?
The market capitalization of Onesource Specialty Pharma Ltd. stands at ₹ 20,155.80 Cr.
What is the dividend yield of Onesource Specialty Pharma Ltd.?
The dividend yield of Onesource Specialty Pharma Ltd. is 0.00% based on the current market price.
What is the RSI of Onesource Specialty Pharma Ltd.?
The Relative Strength Index (RSI) of Onesource Specialty Pharma Ltd. is 53.97.
What is the FII and DII holding in Onesource Specialty Pharma Ltd.?
Foreign Institutional Investors (FII) hold 19.39% and Domestic Institutional Investors (DII) hold 11.36% of Onesource Specialty Pharma Ltd. shares.
What sector does Onesource Specialty Pharma Ltd. belong to?
Onesource Specialty Pharma Ltd. operates in the Healthcare sector.
What is the beta of Onesource Specialty Pharma Ltd. stock?
The beta of Onesource Specialty Pharma Ltd. stock is -, indicating its volatility relative to the broader market.
